{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:31:31Z","timestamp":1758893491917},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-48259"],"award-info":[{"award-number":["HL-48259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jacl.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T19:31:24Z","timestamp":1482953484000},"page":"215-223","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Q.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacl.2016.12.008_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jacl.2016.12.008_bib2","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.99.19.2517","article-title":"Thrombogenic factors and recurrent coronary events","volume":"99","author":"Moss","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2016.12.008_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","author":"Ingelsson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2016.12.008_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2016.12.008_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.atherosclerosis.2003.08.027","article-title":"Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients","volume":"171","author":"Corsetti","year":"2003","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2016.12.008_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erc.11.182","article-title":"HDL dysfunction in diabetes: causes and possible treatments","volume":"10","author":"Farbstein","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"10.1016\/j.jacl.2016.12.008_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(03)00162-0","article-title":"Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients","volume":"91","author":"Harb","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2016.12.008_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2007.07.077","article-title":"Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction","volume":"101","author":"Mieszczanska","year":"2008","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.jacl.2016.12.008_bib9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jacl.2016.12.008_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jacl.2016.12.008_bib11","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jacl.2016.12.008_bib12","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1074\/jbc.M411484200","article-title":"Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport","volume":"280","author":"Shao","year":"2005","journal-title":"J Biol Chem"},{"issue":"35","key":"10.1016\/j.jacl.2016.12.008_bib13","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jacl.2016.12.008_bib14","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.jacl.2016.12.008_bib15","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","article-title":"Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition","volume":"261","author":"Coetzee","year":"1986","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jacl.2016.12.008_bib16","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/S0022-2275(20)37469-1","article-title":"HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease","volume":"37","author":"Cabana","year":"1996","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jacl.2016.12.008_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.atherosclerosis.2013.08.036","article-title":"Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study","volume":"231","author":"Tehrani","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2016.12.008_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2005.09.012","article-title":"Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation","volume":"187","author":"Corsetti","year":"2006","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2016.12.008_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jacl.2016.12.008_bib20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","article-title":"von Willebrand factor, endothelial dysfunction, and cardiovascular disease","volume":"4","author":"Vischer","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.jacl.2016.12.008_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2013.03.089","article-title":"Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches","volume":"62","author":"Tousoulis","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2016.12.008_bib22","first-page":"791","article-title":"Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators","volume":"86","author":"Zareba","year":"2001","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.jacl.2016.12.008_bib23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/clinchem\/47.8.1498","article-title":"Biological variation of serum amyloid A in healthy subjects","volume":"47","author":"d'Eril","year":"2001","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.jacl.2016.12.008_bib24","first-page":"96","article-title":"Levels of the serum amyloid A protein (SAA) in normal persons of different age groups","volume":"35","author":"Hijmans","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.jacl.2016.12.008_bib25","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/01.CIR.96.9.2914","article-title":"Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes","volume":"96","author":"Fyfe","year":"1997","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741630455X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741630455X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T04:25:44Z","timestamp":1658291144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741630455X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S193328741630455X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2016.12.008","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}